Chemed (NYSE:CHE) announced its earnings results on Wednesday. The company reported $4.41 earnings per share for the quarter, topping the consensus estimate of $3.75 by $0.66, MarketWatch Earnings reports. Chemed had a net margin of 12.99% and a return on equity of 37.46%. The firm had revenue of $502.20 million for the quarter, compared to the consensus estimate of $522.90 million. During the same period in the prior year, the firm earned $3.36 EPS. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. Chemed updated its FY 2020
After-Hours guidance to 16.20-16.40 EPS and its FY20 guidance to $16.20-16.40 EPS.

NYSE CHE traded down $15.99 on Friday, hitting $480.63. 40,247 shares of the stock were exchanged, compared to its average volume of 77,729. The company has a quick ratio of 0.78, a current ratio of 0.81 and a debt-to-equity ratio of 0.36. Chemed has a fifty-two week low of $330.01 and a fifty-two week high of $513.75. The company has a market cap of $7.63 billion, a PE ratio of 31.21, a PEG ratio of 2.93 and a beta of 0.70. The company has a 50-day moving average price of $461.14 and a 200-day moving average price of $451.73.

Separately, Zacks Investment Research raised shares of Chemed from a “hold” rating to a “buy” rating and set a $489.00 target price on the stock in a research note on Tuesday, May 19th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $509.80.

In other news, Director Patrick P. Grace sold 1,520 shares of the company’s stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $450.18, for a total value of $684,273.60. Following the completion of the transaction, the director now owns 4,399 shares in the company, valued at approximately $1,980,341.82. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, VP Naomi C. Dallob sold 2,200 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $430.00, for a total transaction of $946,000.00. Following the completion of the transaction, the vice president now owns 2,347 shares of the company’s stock, valued at approximately $1,009,210. The disclosure for this sale can be found here. Insiders have sold a total of 16,020 shares of company stock valued at $7,212,353 in the last quarter. 3.96% of the stock is currently owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Further Reading: What is the balance sheet?

Earnings History for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.